Perfusion drugs for non‑muscle invasive bladder cancer (Review)-Reference-Cited by-同舟云学术

Perfusion drugs for non‑muscle invasive bladder cancer (Review)

Published:2024-04-15 Issue:6 Volume:27 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Qian Jingyuan¹,Zhang Qiuchen²,Cao Yang³,Chu Xi³,Gao Yiyang³,Xu Haifei⁴,Cai Hongzhou³,Wu Jiajia⁵

Affiliation:

1. Department of Nursing, Jiangsu Cancer Hospital and The Affiliated Cancer Hospital of Nanjing Medical University and Jiangsu Institute of Cancer Research, Nanjing, Jiangsu 210009, P.R. China

2. Department of Urology, Jiangsu Cancer Hospital and The Affiliated Cancer Hospital of Nanjing Medical University and Jiangsu Institute of Cancer Research, Nanjing, Jiangsu 210009, P.R. China

3. Department of Urology, Jiangsu Cancer Hospital and The Affiliated Cancer Hospital of Nanjing Medical University and Jiangsu Institute of Cancer Research, Nanjing, Jiangsu 210009, P.R. China

4. Department of Urology, Nantong Tumor Hospital, Nantong, Jiangsu 226006, P.R. China

5. Department of Nursing, Jiangsu Cancer Hospital and The Affiliated Cancer Hospital of Nanjing Medical University and Jiangsu Institute of Cancer Research, Nanjing, Jiangsu 210009, P.R. China

Publisher

Spandidos Publications

Reference98 articles.

1. Cancer statistics, 2023;Siegel;CA Cancer J Clin,2023

2. The many faces of urothelial carcinomas: An update from pathology to clinical approach and challenges in practice;Enneli;Urol Res Pract,2023

3. Bladder Cancer;Clark;J Natl Compr Canc Netw,2013

4. Reactions of ethyleneimine with guanosine and deoxyguanosine;Hemminki;Chem Biol Interact,1984

5. Covalent modification of DNA by antineoplastic agents;Hemminki;J Natl Cancer Inst,1984